Prohibits the state, participating ERISA, or any health plan from purchasing referenced drugs for a cost higher than the referenced rate.

Rhode Island Bill Summary: Prescription Drug Cost Protection

This bill would set limits on how much the state of Rhode Island, certain employer health plans, and other health insurance plans can pay for specific prescription drugs. It works by establishing a "referenced rate" — essentially a price cap — for certain medications, and then prohibiting any covered health plan from paying more than that capped price. The goal is to prevent overpaying for drugs that have been identified as costing more than a benchmark amount.

The bill would affect a wide range of people and organizations. State employees and Medicaid recipients could benefit if the state's health programs are restricted from overpaying for medications. Workers enrolled in certain employer-sponsored health plans (known as ERISA plans) and people covered under other qualifying health insurance plans could also be impacted. Essentially, if your health coverage falls under one of these categories, this bill could influence what your plan pays for certain prescription drugs.

The practical effect could mean lower costs for health plans, which could potentially translate into savings for employers, taxpayers, and even individual patients through lower premiums or out-of-pocket costs. However, it's worth noting that drug manufacturers and pharmacies might respond in various ways, such as adjusting availability of certain drugs in the state.

Currently, the bill has been referred to the Senate Health and Human Services Committee and has been recommended for further study, meaning legislators want to examine it more closely before moving it forward. It has not yet been voted on or passed into law.